Anakinra injection

Anakinra injection

Form: Injection(SQ)

Strength: 100 mg/mL

Reference Brands: Kinerso, Kineret(US)

Category: Immune Disorder

Anakinra prefilled pens, marketed as Kineret, are approved in both the US by the FDA and in the EU via EMA for rheumatoid arthritis, Still's disease, and autoinflammatory conditions. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety, manufacturing quality, and pharmacovigilance data. In the US, the FDA reviews detailed clinical trial and manufacturing information, while the EMA ensures compliance with regional standards. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring compliance is essential for timely approval, supporting safe and effective treatment options for autoimmune and autoinflammatory diseases worldwide.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Belimumab prefilled syringe

Strength: 200 mg/ten 1 mL for SQ; 10 mg/mL for IV

Form: Subcutaneous (SC) and intravenous (IV) Prefilled syringe

Reference Brands: Benlysta(US & EU)

View Details Get Enquiry
IVIG (Intravenous Immunoglobulin) solution

Strength: 5% or 10%

Form: Intravenous infusion

Reference Brands: Gammagard (Gamunex-C, Flebogamma),Privigen, Octagam, Gamunex-C(US)

View Details Get Enquiry
Ustekinumab Injection

Strength: SQ:: 45 mg, 90 mg; IV: 130 mg/vial

Form: SQ and IV injection

Reference Brands: Stelara(US)

View Details Get Enquiry
Everolimus tablets

Strength: 0.75 mg, 1.25 mg, 2.5 mg, 5 mg, 7.5 mg, 10 mg

Form: Tablet

Reference Brands: Zortress, Afinitor(US & EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.